Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Cannabis-based medicine reduces central pain scores in MS patients

Oct. 13, 2005

Alpharma to study abuse-resistant extended-release opioid in phase II study

Oct. 13, 2005

LXR - a novel therapeutic target for MS

Oct. 13, 2005

Endocannabinoid improves clinical scores in MS mice

Oct. 13, 2005

New potential analgesic agents in early development

Oct. 11, 2005

Ambien CR available in U.S. for insomnia

Oct. 11, 2005

Treg cells exposed to JJ-316 protect against EAE

Oct. 11, 2005

ADX-47273 - a novel mGluR5-positive allosteric modulator

Oct. 11, 2005

New data on the role of mGlu receptors in schizophrenia and anxiety disorders

Oct. 10, 2005

Recent patents cover novel treatments for Parkinson's disease, Alzheimer's disease, etc.

Oct. 10, 2005

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...